Tech Company Financing Transactions

Viva Biotech Funding Round

Viva Biotech, based in Shanghai, secured $210 million from HighLight Capital, Temasek and True Light.

Transaction Overview

Company Name
Announced On
11/21/2023
Transaction Type
Venture Equity
Amount
$210,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
No.735, Ziping Road, Pudong New Area
Shanghai, 201318
CN
Email Address
Overview
Established in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage structure-based drug R&D to commercial manufacturing to global biopharmaceutical innovators. We offer leading early-stage to late-phase drug discovery expertise by integrating our dedicated team of experts, cutting-edge technology platforms, and state-of-the-art equipment in X-ray crystallization, Cryo-EM, ASMS, SPR, HDX, CADD, and much more. Our business covers all aspects of therapeutic strategies and drug modalities, including small molecules and biologics across the pharma and biotech spectrum. The experienced chemistry team, led by senior medicinal chemists and drug discovery biologists, provides services for drug design, medicinal chemistry (hit to lead and lead optimization), custom synthesis, chemical analysis and purification, kilogram scale-up, peptide synthesis and corresponding bioassays. With our subsidiary, Langhua Pharmaceutical, we offer our worldwide pharmaceutical and biot
Profile
Viva Biotech LinkedIn Company Profile
Social Media
Viva Biotech Company Twitter Account
Company News
Viva Biotech News
Facebook
Viva Biotech on Facebook
YouTube
Viva Biotech on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Cheney Mao
  Cheney Mao LinkedIn Profile  Cheney Mao Twitter Account  Cheney Mao News  Cheney Mao on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/21/2023: Layer AI venture capital transaction
Next: 11/21/2023: Supira Medical venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document tech company VC transactions. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary